Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

FDA accept New Drug Application for Obseva’s linzagolix

November 22, 2021 Sales and Marketing

Obseva, a biopharmaceutical company developing and commercialising novel therapies to improve reproductive health, have announced that the NDA for linzagolix …
News

Novel mechanisms could transform standards of care in multiple cancers, MS, and Lupus

November 22, 2021 Sales and Marketing

Leading science and technology company, Merck KGaA, Darmstadt, Germany have identified five mid- to late-stage assets with first-in-class potential for …
News

Scientists uncover factors influencing waning immunity with Pfizer COVID-19 vaccine

November 22, 2021 Sales and Marketing

Scientists have discovered multiple factors influencing declining immunity over time with the Pfizer COVID-19 vaccine, according to News Medical.
News

Emergex trial new form of COVID vaccine

November 15, 2021 Sales and Marketing

Emergex, an Oxfordshire based company, is moving towards Phase I trials for its novel COVID-19 vaccine, which is applied as …
News
11347696326_bac61dbf66_e

Theramex launches Femarelle to treat menopause symptoms

November 15, 2021 Sales and Marketing

Theramex recently announced that they have acquired the Femarelle ® product licence to treat menopause symptoms. The commercialisation agreement was reached …
News

Pfizer vaccine generates most antibodies, comparative study suggests

November 15, 2021 Sales and Marketing

Pfizer Inc. and BioNTech’s COVID-19 vaccine yielded the strongest immune response in a comparative study of four vaccines. The study, …
News

First patient dosed in tumour membrane immunotherapy trial

November 15, 2021 Sales and Marketing

Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumour membrane immunotherapy, announced that …
News

BIAL appoints Joerg Holenz as R&D General Manager

November 8, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …
Appointment

Diabetes drug dapagliflozin recommended by NICE for chronic kidney disease

November 8, 2021 Sales and Marketing

A study published in the journal Lancet states that a common diabetes drug may be an option for treating chronic …
News

HLB’s liver cancer treatment awarded Orphan Drug Status by FDA

November 8, 2021 Sales and Marketing

HLB have announced that its anticancer drug candidate, rivoceranib, has been awarded Orphan Drug Status by the FDA. HLB is …
News

UK government to roll out Merck antiviral pill, Pfizer COVID pill cuts hospitalisations by 89%

November 8, 2021 Sales and Marketing

The UK government will roll out Merck’s COVID-19 antiviral pill, molnupiravir, through drug trial later this month. In early November, …
News
kjm_cropped

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …
Appointment

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …
Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
Feature
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …
Appointment
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026